The Development And Evaluation Of Primary Prevention Management Pathway For Ischemic Stroke

Objective To develop a ischemic stroke primary prevention mangement pathway(ISPPMP)for a community hospital.And to evaluate the effectiveness and feasibility of the management pathway.Methods(1)selected 100 patients from June 2017 to December 2017 in Mishixiang community health service center,there are 54 males and 46 females.All the patients were randomly divided into experimental group(n = 50)and the control group(n = 50)according to “the estimating 10-year risk of ICVD scale in Chinese”.The experimental group was treated in ischemic stroke primary prevention management pathway,The control group was treated in routine way.In 3 months and 6 months,respectively,compared with the two groups of patients with ischemic stroke related knowledge awareness,body index,blood pressure,blood fat and fasting blood-glucose.Through the SPSS22.0 statistical software to analyze the results.Results 1.through the health education,in the aspect of the risks,early warnings,complications of ischemic stroke,the experimental group compared with the control group,the difference is statistically significant(P< 0.05).In the aspect of therapies,the difference isn't statistically significant(P > 0.05).2.the Basic indicators of intermediate danger or below group: Compared with the control group,the patients of body index and SBP in intermediate danger or below,the difference isn't statistically significant(P > 0.05).Compared with in intervened before and 6 months after the intervention,the male and female patients' BMI in the experimental group,the difference is statistically significant(P< 0.05).And after 3months and 6 months intervention,the males' SBP in the experimental group compared to intervened before,and the females were after 6 months intervention,the difference is statistically significant(P< 0.05).3.the Basic indicators of the high risk or higher group: Compared with the control group,the female patients' BMI in the experimental group after 3 months and 6months intervention,the difference is statistically significant(P< 0.05).The male patients' BMI after 6 months intervention,the difference is statistically significant(P<0.05).Compared with the control group,the patients of SBP,the difference isn't statistically significant(P > 0.05).4.the Laboratory indicators of intermediate danger or below group: Compared with the control group,the patients of fasting blood-glucose and total cholesterol in intermediate danger or below,the difference isn't statistically significant(P > 0.05).The female patients' FBG after 3 months and 6 months intervention,the difference is statistically significant(P< 0.05);The male patients' TC after 3 months and 6 months intervention,the difference is statistically significant(P< 0.05);5.the Laboratory indicators of the high risk or higher group: Compared with the control group,the patients of fasting blood-glucose,the difference isn't statistically significant(P > 0.05).Compared with the control group,the male patients' TC after 6months intervention,the difference is statistically significant(P< 0.05);the female patients' TC after 3 months and 6 months intervention,the difference is statistically significant(P< 0.05).6.Compared with the control group,the diagnosis,the treatment in the experimental group,the difference is statistically significant(P< 0.05);And about the timeliness of treatment,the process and the fee,the difference isn't statistically significant(P >0.05).Conclusion(1)Through health education can enhance patients awareness of related knowledge of ischemic stroke,improve the patients of lifestyle change initiative and medicine compliance,so as to reduce the incidence of ischemic stroke.(2)Through the ISPPCP can reduce the risk factors of stroke,such as obesity,high blood pressure,hyperglycemia,hyperlipidemia,thus reduce morbidity and mortality of ischemic stroke.(3)Through the ISPPCP can improve management quality and increase the satisfaction of patients.